STANDARD · Conviction 5/10Zamazenta V from the Sword & Shield set (#212) currently trades at €14.50 in the raw market. Over the past 30 days the card has declined -4.1%. By market value it ranks #11 of 554 in Sword & Shield — the 100th percentile of the set. PSA 10 copies command 511% over raw. With recent sales tracked over the trailing 180 days, liquidity is rated high. Read together, a top-tier ranking in Sword & Shield alongside softening 30-day momentum frames where Zamazenta V sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.
€14.50 (raw, market average).
A PSA 10 sells for roughly 511% over raw — but whether grading actually pays depends on the realistic grade mix (you usually pull a 9, not a 10) and the ~$25 fee. Sign up free to see the grade-or-sell verdict for Zamazenta V.
It ranks #11 of 554 cards by market value, in the 100th percentile of the set.
It has declined -4.1% over the past 30 days.
60 raw-NM sales tracked over the trailing 180 days.
▲ 16.6%
▼ 13.6%
▼ 82.2%
▲ 18.4%
▼ 24.8%
▼ 68.5%
